HomeNewsBusinessStocksBuy Ambuja Cements; target of Rs 260: Religare Capital

Buy Ambuja Cements; target of Rs 260: Religare Capital

Religare Capital is bullish on Ambuja Cements and has recommended buy rating on the stock with a target of Rs 260 in its October 30, 2014 research report.

November 12, 2014 / 15:01 IST
Story continues below Advertisement

Religare Capital`s research report on Ambuja CementsRevenues in line: Topline grew 9% YoY to Rs 22bn driven by an 11% growth in realisations, even as volumes dipped 2% YoY. QoQ, realisations declined by ~2% (RCMLe: -2.5%) due to a correction in prices across regions (except the south). EBITDA/t ahead of estimates at Rs 788: Higher realisations negated the impact of cost pressures, enabling ACEM to clock an EBITDA/t of Rs 788 (RCMLe: Rs 750), higher Rs 266 YoY/lower Rs 194 QoQ. While RM cost/t slid YoY (higher QoQ) owing to inventory adjustments, other costs jumped across most line items YoY. Power & fuel costs shot up 13.5% YoY (but remained flat QoQ). Freight costs rose 6.3% YoY due to higher diesel prices, while lower operating efficiencies pushed up other expenses YoY. PAT at Rs 2.4bn (+91% YoY; in line with estimates) was boosted by better operating profits and higher other income. Maintain BUY: We cut our CY14/CY15/CY16 estimates by 5%/5%/4% (to build in lower volumes/higher cost) and roll over to a Dec’15 of 260 (based on 11x one-year fwd. EV/EBITDA). A major presence in the key north and west regions augurs well for the company’s volume/price growth over the next few years as we expect utilisation levels in these regions to touch 90%+. We maintain BUY and would recommend accumulating the stock on any weakness. "ACEM reported an in-line Q3 PAT of Rs 2.4bn but a slightly higher-than-estimated EBITDA/t of Rs 788 (RCMLe: Rs 750; +Rs 266 YoY/-Rs 194 QoQ), as sharper-than-expected realisation growth negated cost pressures across the board. We adjust our estimates for lower volumes, and roll over to a Dec’15 TP of Rs 260 (from a Sep’15 TP of Rs 255) set at 11x one-year fwd. EV/EBITDA. We expect ACEM to report better realisations ahead as it benefits from higher utilisation (90%+ in the north/west) over the next 2–3 years. BUY,” says Religare Capital research report. 

For all recommendations, click here 

Story continues below Advertisement

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

first published: Nov 12, 2014 03:01 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!